Trial Profile
Quantitating the Impact of Plerixafor Alone or in Combination With Bortezomib on Plasma Cell Mobilization and the Subsequent Impact on HLA Antibody Levels
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 06 Jun 2022
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Bortezomib
- Indications Stem cell mobilisation
- Focus Pharmacodynamics; Proof of concept
- 29 Jun 2020 Planned End Date changed from 1 Dec 2019 to 1 Oct 2020.
- 29 Jun 2020 Planned primary completion date changed from 1 Sep 2019 to 1 Sep 2020.
- 19 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.